Lynn Barr, a Value-Based Payment and 340B Champion, is Appointed to MedPAC

New MedPAC Commissioner Lynn Barr says. “I see first-hand how important the 340B program is to safety net patients and providers."

Lynn Barr, the founder and executive chair of a company that helps health systems implement value-based payment models and maximize 340B savings, has been appointed to the Medicaid Payment Advisory Commission (MedPAC).

U.S. Comptroller General Gene Dodaro announced Barr’s appointment

Read More »

Judge Declines to Issue Stays Against HRSA Stemming from its May 17 Demand Letters

A federal district judge in Trenton, N.J., this week denied drug makers’ Novo Nordisk and Sanofi’s motions to temporarily stop federal health officials from forcing the companies to immediately resume offering 340B pricing when covered entities use contract pharmacies.

A federal district judge in Trenton, N.J., this week denied drug makers’ Novo Nordisk and Sanofi’s motions to temporarily stop federal health officials from forcing the companies to immediately resume offering 340B pricing when covered entities use contract pharmacies. If

Read More »

340B DSH Hospitals More Likely To Treat Black, Disabled, and Low-Income Patients With Chronic Conditions, Study Indicates

A new hospital-funded study found that 340B disproportionate share (DSH) hospital outpatient departments are more likely than other hospital outpatient departments and independent physician offices to treat Medicare beneficiaries with chronic conditions who are Black, disabled, or who have low incomes. | Shutterstock

340B disproportionate share (DSH) hospital outpatient departments are more likely than other hospital outpatient departments and independent physician offices to treat Medicare beneficiaries with chronic conditions who are Black, disabled, or who have low incomes, a new 340B hospital-funded study

Read More »

CMS Moves to Delay Multiple-Best-Price Rule For Value-Based Drug Purchases

CMS has proposed delaying the effective date of a rule that would allow multiple best prices in value-based drug purchasing arrangements. | Shutterstock

The U.S. Centers for Medicare & Medicaid Services (CMS) has proposed to delay implementing a portion of a regulation encouraging value-based purchasing for drugs in the Medicaid program that may lead to drugs having multiple best prices.

Finalized during the

Read More »

Sanofi and Novartis Fight HRSA’s 340B Contract Pharmacy Demand Letters

Sanofi yesterday sent HRSA a long letter defending its limits on 340B contract pharmacy. | Shutterstock

Drug manufacturer Sanofi yesterday sent the U.S. Health Resources and Services Administration (HRSA) a 30-page defense of its requirement that 340B covered entities must submit their contract pharmacy claims data to a vendor to continue to be able to access

Read More »

340B Hospitals Ask Supreme Court Again to End Steep Medicare Drug Payment Cut

The U.S. Supreme Court this morning agreed to take up a case regarding Medicare Part B cuts to 340B hospitals. | Shutterstock

National hospital groups urged the U.S. Supreme Court last Friday to review and reverse a federal appellate decision upholding a steep cut in hospitals’ Medicare Part B reimbursement for 340B-purchased drugs.

The American Hospital Association (AHA), the Association of American

Read More »

Two Drug Makers Providing Refunds for 340B Overcharges

Drug manufacturers Xellia and Chartwell have notified 340B covered entities about possible refunds for overcharges. | Shutterstock

Drug manufacturers Xellia Pharmaceuticals and Chartwell Rx have notified 340B covered entities about possible refunds for overcharges.

Xellia Pharmaceuticals

Xellia notified 340B covered entities about refunds for overcharges on 16 NDCs for its antibiotics vancomycin, daptomycin, and colistimethate.

Xellia posted

Read More »

Brooks-LaSure Sworn in as CMS Administrator

HHS Secretary Xavier Becerra (left) administers the oath of office to new CMS Administrator Chiquita Brooks-LaSure as her husband, Allyn Brooks-LaSure looks on.

Chiquita Brooks-LaSure last Thursday was formally sworn in as Administrator of the Centers for Medicare and Medicaid Services (CMS), setting in place another key Biden administration official with influence on the 340B program.

Although CMS does not control federal 340B

Read More »

Grassroots Group Launches Regional Events to Promote 340B’s Importance

Community Voices for 340B (CV340B) promotes awareness of the 340B program through in-person seminars and webinars.

Community Voices for 340B (CV340B), the first non-profit grassroots organization focused on promoting the importance of the 340B program, kicked off the first of series of regional educational webinars scheduled last week. The event, which was focused on the Northeast

Read More »

Breaking News

BREAKING: Novartis Sues HRSA in Defense of its 340B Contract Pharmacy Policy

Novartis sued HRSA yesterday to stop it from enforcing its interpretation of the 340B statute's contract pharmacy requirements, and from imposing civil monetary penalties against Novartis for alleged violations. | Shutterstock

Novartis Pharmaceuticals has sued the U.S. Health Resources and Services Administration (HRSA) over the agency’s May 17 letter telling the company its restrictions on 340B pricing to covered entities that use contract pharmacies are illegal.

Novartis told 340B Report late

Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live